Can 18F-FDG PET/CT predict EGFR status in patients with non-small cell lung cancer? A systematic review and meta-analysis

Volume: 11, Issue: 6, Pages: e044313 - e044313
Published: Jun 1, 2021
Abstract
Objectives This study aimed to explore the diagnostic significance of 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography (PET)/CT for predicting the presence of epidermal growth factor receptor ( EGFR ) mutations in patients with non-small cell lung cancer (NSCLC). Design A systematic review and meta-analysis. Data sources The PubMed, EMBASE and Cochrane library databases were searched from the earliest available date to December...
Paper Details
Title
Can 18F-FDG PET/CT predict EGFR status in patients with non-small cell lung cancer? A systematic review and meta-analysis
Published Date
Jun 1, 2021
Journal
Volume
11
Issue
6
Pages
e044313 - e044313
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.